Dr. Arbour on the Latest Data for Checkpoint Inhibitors for Lung Cancer in 2019

Leggi l'articolo originale


Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.

Lascia un commento